Literature DB >> 33825869

Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.

Jens T Van Praet1,2, Stefaan Vandecasteele1, Anneleen De Roo3, An S De Vriese1,2, Marijke Reynders4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33825869      PMCID： PMC8083580          DOI： 10.1093/cid/ciab300

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  39 in total

1.  Emerging Evidence on Effectiveness of COVID-19 Vaccines Among Residents of Long-Term Care Facilities.

Authors:  Maximilian Salcher-Konrad; Siân Smith; Adelina Comas-Herrera
Journal:  J Am Med Dir Assoc       Date:  2021-05-25       Impact factor: 4.669

2.  Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.

Authors:  Jens Van Praet; Marijke Reynders; Dirk De Bacquer; Liesbeth Viaene; Melanie K Schoutteten; Rogier Caluwé; Peter Doubel; Line Heylen; Annelies V De Bel; Bruno Van Vlem; Deborah Steensels; An S De Vriese
Journal:  J Am Soc Nephrol       Date:  2021-09-29       Impact factor: 10.121

Review 3.  Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021.

Authors:  Chang-Jie Cheng; Chun-Yi Lu; Ya-Hui Chang; Yu Sun; Hai-Jui Chu; Chun-Yu Lee; Chang-Hsiu Liu; Cheng-Huai Lin; Chien-Jung Lu; Chung-Yi Li
Journal:  Vaccines (Basel)       Date:  2021-12-16

4.  Previous SARS-CoV-2 Infection, Age, and Frailty Are Associated With 6-Month Vaccine-Induced Anti-Spike Antibody Titer in Nursing Home Residents.

Authors:  Adam H Dyer; Claire Noonan; Matt McElheron; Isabella Batten; Conor Reddy; Emma Connolly; Rachel Pierpoint; Caroline Murray; Ann Leonard; Catriona Higgins; Phyllis Reilly; Gerard Boran; Thomas Phelan; William McCormack; Desmond O'Neill; Aoife Fallon; Gareth Brady; Cliona O'Farrelly; Nollaig M Bourke; Sean P Kennelly
Journal:  J Am Med Dir Assoc       Date:  2022-01-11       Impact factor: 7.802

5.  Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial.

Authors:  Anxo Fernández-Ferreiro; Francisco J Formigo-Couceiro; Roi Veiga-Gutierrez; Jose A Maldonado-Lobón; Ana M Hermida-Cao; Carlos Rodriguez; Oscar Bañuelos; Mónica Olivares; Ruth Blanco-Rojo
Journal:  Nutrients       Date:  2022-01-05       Impact factor: 5.717

6.  Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.

Authors:  Patricia Almendro-Vázquez; Rocio Laguna-Goya; Maria Ruiz-Ruigomez; Alberto Utrero-Rico; Antonio Lalueza; Guillermo Maestro de la Calle; Pilar Delgado; Luis Perez-Ordoño; Eva Muro; Juan Vila; Isabel Zamarron; Miguel Moreno-Batanero; Marta Chivite-Lacaba; Francisco Javier Gil-Etayo; Carmen Martín-Higuera; María Ángeles Meléndez-Carmona; Carlos Lumbreras; Irene Arellano; Balbino Alarcon; Luis Miguel Allende; Jose Maria Aguado; Estela Paz-Artal
Journal:  PLoS Pathog       Date:  2021-12-28       Impact factor: 6.823

7.  Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.

Authors:  Gian Luca Salvagno; Brandon M Henry; Giovanni di Piazza; Laura Pighi; Simone De Nitto; Damiano Bragantini; Gian Luca Gianfilippi; Giuseppe Lippi
Journal:  Diagnostics (Basel)       Date:  2021-05-04

8.  The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study.

Authors:  Daisuke Jubishi; Koh Okamoto; Kensuke Hamada; Takashi Ishii; Hideki Hashimoto; Takayuki Shinohara; Marie Yamashita; Yuji Wakimoto; Amato Otani; Naoko Hisasue; Mahoko Ikeda; Sohei Harada; Shu Okugawa; Kyoji Moriya; Shintaro Yanagimoto
Journal:  Hum Vaccin Immunother       Date:  2022-03-25       Impact factor: 4.526

9.  Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination.

Authors:  Ekaterina Kurteva; Georgi Vasilev; Kalina Tumangelova-Yuzeir; Irena Ivanova; Ekaterina Ivanova-Todorova; Tsvetelina Velikova; Dobroslav Kyurkchiev
Journal:  Rheumatol Int       Date:  2022-01-20       Impact factor: 3.580

10.  BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.

Authors:  Quentin Moyon; Delphine Sterlin; Makoto Miyara; François Anna; Guy Gorochov; Zahir Amoura; Alexis Mathian; Raphael Lhote; Pascale Ghillani-Dalbin; Paul Breillat; Sasi Mudumba; Sophia de Alba; Fleur Cohen-Aubart; Julien Haroche; Micheline Pha; Thi Huong Du Boutin; Hedi Chaieb; Pedro Macedo Flores; Pierre Charneau
Journal:  Ann Rheum Dis       Date:  2021-10-04       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.